Chart, page-983

Assuming the poster prize committee worked like all the ones I have ever seen they had 5 minutes, 10 minutes tops, to look at the poster and ask questions. They don't have the time to look up past work or references or even have the time to go into the details of the data on the poster. On top of this they are not trying to assess the likelihood of BIT landing a pharma deal.

My conclusion is better not because I know more about the area, but because I have put in far more time into working out what is BIT225 commercial potential.

To answer your question if they spent the same amount of time as me I think the committee would reach a similar conclusion to me as to what the issues are with the data. I should add the conclusions on the poster are quite different to the claims that had been made by the company in their original announcement and the ASX awareness letter.